Transjugular liver biopsy yields high-quality samples

Major complications due to transjugular liver biopsy: Incidence, management and outcome

“…Lebrec et al found that complications correlated with an increase in the number of passes necessary to obtain adequate hepatic tissue samples [2] although others found that the occurrence of major complication did not correlate with the number of samples taken [9]. In our study, only two needle passes were performed in the two patients with intraperitoneal bleeding, but this does not allow drawing particular conclusion.…”

“…It is well-established that in patients with severe coagulation abnormalities or ascites, standard percutaneous liver biopsy is associated with a high risk of hemoperitoneum, which can be lifethreatening and even fatal [7,11]. To avoid these risks TJLB is a satisfactory alternate option [2,6,9,[14][15][16][17].…”

“…Transjugular liver biopsy (TJLB) is used for obtaining highquality histological samples from patients with acute or chronic liver disease who have severe coagulation abnormalities or ascites for whom standard percutaneous biopsy of the liver is contraindicated [1][2][3][4][5][6][7][8][9][10][11][12][13]. It is well-established that in patients with severe coagulation abnormalities or ascites, standard percutaneous liver biopsy is associated with a high risk of hemoperitoneum, which can be lifethreatening and even fatal [7,11].…”

Modern Possibilities of Endosurgical Biopsy in Children with Chronic Liver Diseases

“…При проведении биопсии печени трансъюгуляр-ным/трансфеморальным доступом иглу проводят в одну из печеночных вен с дальнейшей пункцией печеночной ткани через стенку сосуда, вследствие чего снижает-ся вероятность развития гематологических осложнений (внутрибрюшное и внутрипеченочное кровотечение) [9,27]. L. Jeffers и соавт.…”

Complications majeures de la biopsie hépatique transjugulaire : incidence, prise en charge et évolution

“…La biopsie hépatique transjugulaire (BHTJ) est utilisée pour obtenir des échantillons histologiques de haute qualité chez des patients atteints de maladie hépatique aiguë ou chronique et présentant des anomalies de la coagulation ou une ascite sévères, et chez lesquels une biopsie hépa-tique percutanée standard est contre-indiquée [1][2][3][4][5][6][7][8][9][10][11][12][13]. Il est bien établi que, chez les patients présentant des anomalies de la coagulation ou une ascite sévères, une biopsie hépatique percutanée standard comporte un risque élevé d'hémopéritoine, une complication engageant le pronostic vital et parfois fatale [7,11].…”